PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 26, 2007
Insider Transaction Report
Form 4
Kremer Alton B
VP, Clinical Research
Transactions
- Disposition to Issuer
Common Stock
2007-06-21$22.51/sh−400$9,004→ 16,990 total - Disposition to Issuer
Common Stock
2007-06-21$22.78/sh−100$2,278→ 16,165 total - Disposition to Issuer
Common Stock
2007-06-21$22.76/sh−300$6,828→ 16,490 total - Disposition to Issuer
Common Stock
2007-06-21$22.77/sh−225$5,123→ 16,265 total - Disposition to Issuer
Common Stock
2007-06-21$22.46/sh−1,075$24,145→ 17,390 total - Disposition to Issuer
Common Stock
2007-06-21$22.62/sh−200$4,524→ 16,790 total
Footnotes (1)
- [F1]Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer.